<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Rejection after allogeneic BMT for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> is a complication with a high risk of mortality </plain></SENT>
<SENT sid="1" pm="."><plain>We describe a patient who, following a second episode of rejection after a second BMT entered a third durable remission subsequent to treatment with ALG, donor lymphocyte infusions, GM-CSF, and erythropoietin </plain></SENT>
<SENT sid="2" pm="."><plain>Therapy was well tolerated </plain></SENT>
<SENT sid="3" pm="."><plain>At 5 years after rejection treatment, his hematopoiesis is of complete donor origin as determined by analyses of short tandem repeats </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, donor lymphocyte infusions can be considered as a therapy option for marrow rejection after allogeneic BMT for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>